Description

Buy Axepta 60: Advanced Non-Stimulant Support for ADHD

Axepta 60 is a prescription-only medicine (POM). It contains Atomoxetine Hydrochloride 60mg as its active ingredient. Intas Pharmaceuticals Limited is the manufacturer of this medicine. Children aged six and over, adolescents, and adults with Attention Deficit Hyperactivity Disorder (ADHD) are among those for whom this medicine is indicated. It belongs to the Selective Norepinephrine Reuptake Inhibitor (SNRI) class.

Detail	Axepta 60	Strattera (UK Reference Brand)
Active Ingredient	Atomoxetine Hydrochloride	Atomoxetine Hydrochloride
Strength	60mg	60mg
Class	SNRI	SNRI
Manufacturer	Intas Pharmaceuticals Limited	Eli Lilly
POM Status	Yes	Yes

Medicine Composition

Active Ingredient

Atomoxetine 60 mg

Available Strengths

Axepta Is Available in a Variety of Strengths to Suit Different Treatment Needs:

• Axepta 10
• Axepta 18
• Axepta 20
• Axepta 25
• Axepta 40

Manufacturer

Intas Pharmaceuticals Ltd.

Expiry Information

Expiry dates are provided according to the actual batch supplied at the time of purchase.

Mechanism of Action

Atomoxetine Hydrochloride blocks the reuptake (re-absorption) of norepinephrine (a neurotransmitter controlling attention and impulse regulation) in the brain. This increases norepinephrine availability in the prefrontal cortex, improving focus, reducing impulsivity, and supporting behavioural control. As Axepta 60 carries no stimulant properties, its classification under UK law does not place it among controlled substances.

Clinical Uses

• ADHD in children aged six and over, within a comprehensive treatment programme
• ADHD in adolescents requiring long-term management
• ADHD in adults where stimulant therapy is contraindicated or not tolerated
• Continuation of paediatric ADHD treatment into adulthood under specialist review

Safety Information

Side Effect Type	Side Effect	Symptoms / Details
Common	Decreased appetite	Reduced desire to eat
Common	Nausea	Feeling sick, particularly in early treatment
Common	Stomach pain	Abdominal discomfort
Common	Headache	Mild to moderate head pain
Common	Dry mouth	Reduced saliva production
Common	Dizziness	Feeling lightheaded or unsteady
Common	Irritability	Mood changes, heightened frustration
Common	Insomnia	Difficulty falling or staying asleep
Serious	Suicidal thoughts	Particularly in children and adolescents during early treatment
Serious	Severe liver injury	Jaundice, dark urine, or upper abdominal pain
Serious	Cardiovascular effects	Raised heart rate or blood pressure
Serious	Psychotic symptoms	Hallucinations or unusual behaviour
Serious	Severe allergic reactions	Rash, swelling, or breathing difficulty

Report suspected adverse reactions via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Safety Advice

Liver Health

Atomoxetine Hydrochloride has rarely caused serious liver injury. Before treatment begins, your prescriber must be informed of any previous or existing liver disease.

Kidney Health

Patients with renal impairment should inform their prescriber. Dose adjustment may be required under clinical review.

Alcohol

Avoid alcohol whilst taking Axepta 60. Alcohol worsens dizziness and central nervous system side effects.

Driving

During the early stages of treatment, drowsiness may be experienced by some patients taking Axepta 60. Until the effect of this medicine on your alertness is clearly understood, both driving and operating machinery are best avoided.

Pregnancy

Because the safety profile during pregnancy remains incompletely established, use is recommended only under close medical supervision. Prescribing is appropriate only in circumstances where the clinical benefit is judged to clearly outweigh any associated risk.

Breastfeeding

Do not breastfeed whilst taking Axepta 60 without first consulting your doctor.

Accessing Treatment Responsibly

Access Axepta 60 only with a valid prescription from your GP or a pharmacy. Do not obtain Atomoxetine Hydrochloride from unregulated sources.

Frequently Asked Questions

Q: What is the use of Axepta 60?

A: The primary clinical use for which Axepta 60 is prescribed is the management of Attention Deficit Hyperactivity Disorder (ADHD). Improved focus, reduced impulsivity, and greater behavioural control are among the clinical benefits observed in children aged six and over, adolescents, and adults.

Q: Can I take Axepta without food?

A: Yes, Axepta 60 can be taken with or without food. Nausea may be reduced when the medicine is taken alongside food. Timing and dosage must always be followed as directed by your prescriber.

Q: What happens if a non-ADHD person takes Atomoxetine?

A: Atomoxetine Hydrochloride is not intended for people without ADHD. It may cause raised blood pressure, mood changes, or heart-related effects. Never take this medicine without a valid prescription.

Q: Is Axepta an antidepressant?

A: Axepta 60 is not a stimulant. It is a Selective Norepinephrine Reuptake Inhibitor (SNRI), indicated specifically for the management of ADHD. Although it shares a class name with some antidepressants, it is not prescribed for depression.

Q: Does Axepta make me sleepy?

A: Axepta 60 may cause fatigue or drowsiness, particularly during early treatment. Until your individual response to the medicine is established, driving or operating machinery is best avoided.

Conclusion

Axepta 60 (Atomoxetine Hydrochloride 60mg) is a clinically established non-stimulant ADHD medicine. This is completely normal as they contain the same active ingredient. Always consult a qualified UK healthcare professional before starting or changing treatment.

References

• NHS (2024). Atomoxetine. www.nhs.uk
• NICE (2023). ADHD: diagnosis and management (NG87). www.nice.org.uk

Medical Disclamair

This article is for informational purposes only and does not replace professional medical advice. Always consult a registered healthcare professional before starting or changing any treatment. In a medical emergency, call 999 or attend your nearest A&E immediately.